SLC2A1 and hepatocellular carcinoma: However, though phloretin and WZB117 treatments were shown to inhibit HCC cell growth at higher doses, the extent of the effects were minor in comparison with CANA (lower panel of Fig. 2d), which indicated that GLUT1 inhibition might not fully explain the effects of CANA.